Risk factors for new pulmonary tuberculosis patients failing treatment under the revised national tuberculosis control programme, India

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 4, 2009, Pages 521-526

  Singla, R ^a   Srinath, D ^a   Gupta, S ^a   Visalakshi, P ^a   Khalid, U K ^a   Singla, N ^a   Gupta, U A ^a   Bharty, S K ^a   Behera, D ^a  

^a Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases   (India)

Author keywords

Risk factors; Treatment failure; Treatment outcome; Tuberculosis

Indexed keywords

ETHAMBUTOL; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HEALTH PROGRAM; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT FAILURE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INDIA; MALE; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; RISK FACTORS; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 64549145823     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Revised National Tuberculosis Control Programme. Technical guidelines for tuberculosis control. New Delhi, India: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, 1997: pp 17-20.
2. Becerra M C, Freeman J, Bayona J, et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2000; 4: 108-114.
3. Quy H T W, Lan N T N, Borgdoff M W, et al. Drug susceptibility among failures and relapse cases of tuberculosis: is standard retreatment regimen adequate? Int J Tuberc Lung Dis 2003; 7: 631-636.
4. Chavez Pachas A M, Blank R, Smith Fawzi M C, Bayona J, Becerra M C, Mitnick C D. Identifying early treatment failure on Category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int J Tuberc Lung Dis 2004; 8: 52-58.
5. Santha T, Gopi P G, Rajeswari R, et al. Is it worth treating Category I failure patients with Category II regimen? Indian J Tuberc 2005; 52: 203-206.
6. Mishra D, Singh H P. Kuppuswamy's socio-economic status scale-a revision. Indian J Pediatr 2003; 70: 273-274.
7. Falk A, O'Connor J B, Pratt P C. Classification of pulmonary tuberculosis. In: Falk A, O'Connor J B, Pratt P C, Webb J A, Wier J A, Wolinsky E, eds. Diagnosis standards and classification of tuberculosis. Vol 12. New York, NY, USA: National Tuberculosis and Respiratory Disease Association, 1969: pp 68-76.
8. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
9. Altet-Gômez M N, Alcaide J, Godoy P, Romero M A, Hernandez del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13 038 cases. Int J Tuberc Lung Dis 2005; 9: 430-436.
10. Wang J Y, Hsueh P R, Jan I S, et al. The effect of smoking on tuberculosis: different patterns and poorer outcomes. Int J Tuberc Lung Dis 2007; 11: 143-149.
11. Singla R, Osman M M, Khan N, Al-Sharif N, Al-Sayegh M O, Shaikh M A. Factors predicting persistent sputum smear posi- tivity at 2 months after treatment among pulmonary tuberculosis patients. Int J Tuberc Lung Dis 2003; 7: 58-64.
12. Zhao F Z, Levy M H, Wen S. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis 1987; 6: 570-572.
13. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan P J, McAdam K P. Factors determining the outcome of treatment of adult smear-positive tuberculosis in The Gambia. Int J Tuberc Lung Dis 1998; 2: 712-718.
14. Singla R, Singla N, Sarin R, Arora V K. Influence of pre-treatment bacillary load on treatment outcome of pulmonary tuberculosis patients receiving DOTS under Revised National Tuberculosis Control Programme. Indian J Chest Dis Allied Sci 2005; 47: 19-23.
15. Gopi P G, Chandrasekaran V, Subramani R, et al. Association of conversion and cure with initial smear grading among new smear-positive pulmonary tuberculosis patients treated with Category I regimen. Indian J Med Res 2006; 123: 807-814.
16. Harries A D, Nyirenda T E, Kemp J R, Squire B S, Godfrey- Faussett P, Salaniponi F M. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi. Int J Tuberc Lung Dis 2004; 7: 1040- 1044.
17. Kimerling M E, Kluge H, Vezhnina N, et al. Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB. Int J Tuberc Lung Dis 1999; 3: 451-453.
18. Ottmani S E, Zignol M, Bencheikh N, et al. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis 2006; 10: 1367-1372.
19. Ministry of Health and Family Welfare. TB India 2008- RNTCP status report. New Delhi, India: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, 2008.